Tower Research Capital LLC (Trc) Passage Bio, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Passage Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 34 shares of PASG stock, worth $34. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34Holding current value
$34% of portfolio
0.0%Shares
16 transactions
Others Institutions Holding PASG
# of Institutions
52Shares Held
33MCall Options Held
20.3KPut Options Held
500-
Orbimed Advisors LLC San Diego, CA10.1MShares$10.1 Million0.31% of portfolio
-
Versant Venture Management, LLC San Francisco, CA4.96MShares$4.96 Million9.33% of portfolio
-
Vestal Point Capital, LP New York, NY4.5MShares$4.5 Million0.5% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$2.5 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$2.07 Million0.0% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $54.5M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...